---
title: "Cardiovascular & Respiratory Medicines"
ocid: "ocds-r6ebe6-0000635950"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000635950"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000635950.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000635950.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"THE AUTHORITY\")"
published: "2021-04-07"
---

# Cardiovascular & Respiratory Medicines

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")  
Current stage: Award  
OCID: ocds-r6ebe6-0000635950

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000635950)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000635950.json)

## Summary

The procurement process is conducted by The Common Services Agency, commonly known as NHS National Services Scotland, for a Framework Agreement titled "Cardiovascular & Respiratory Medicines." This procurement falls under the health industry category and is based in Edinburgh, UK. The current stage of the tender is "Award," with a total value of £19,491,306. The tender period concluded on 21st December 2020, leading into the award phase. This framework agreement aims to supply various cardiovascular and respiratory medicines across NHS Scotland, divided into fifteen specific categories or lots, each delineating the requirements for suppliers.

This tender presents significant opportunities for businesses engaged in the healthcare and pharmaceutical sectors, particularly for those specialising in the manufacture and distribution of respiratory and cardiovascular medicines. Companies with capabilities in logistics and quality management would be well-suited to compete. The open procurement method allows for multiple suppliers to participate, enhancing the chances for both established and emerging companies in the health industry to engage with Scotland's health boards and contribute to vital public health services.

## Notice

This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into fifteen (15) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

### Lot Information

Epoprostenol powder and solvent (pH10.5) for solution for infusion vials

Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH10.5) for solution for infusion vials to NHS Scotland. The Authority has awarded all products within this lot to a single supplier.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Epoprostenol powder and solvent (pH12) for solution for infusion vials

Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Epinephrine (Adrenaline) Pre-filled syringes

Supply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority has awarded each product line to a single supplier.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Epinephrine (Adrenaline) Auto Injector Devices

Supply of Epinephrine (Adrenaline) Auto Injector Devices to NHS Scotland in a range of presentations. The Authority has awarded each product line to a single supplier.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Fondaparinux Sodium Pre-filled Syringes

Supply of Fondaparinux Sodium Pre-filled Syringes to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to two (2) Framework Participants.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Urokinase Injections

Supply of Urokinase Injections to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Suppliers will be awarded. Full details can be found within the ITT.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire

Isosorbide Mononitrate Modified Release Capsules and Tablets

Supply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to six (6) Framework Participants.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Diltiazem Hydrochloride Modified Release Capsules and Tablets

Supply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to six (6) Framework Participants.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Verapamil Hydrochloride Modified Release Capsules and Tablets

Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line to a single supplier.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Nifedipine Modified Release Capsules and Tablets

Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to three (3) Framework Participants.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Theophylline Modified Release Capsules and Tablets

Supply of Theophylline Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line to a single supplier.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Bosentan Tablets

Supply of Bosentan Tablets to NHS Scotland. The Authority has awarded this Lot as a multi-supplier unranked framework to five (5) Framework Participants.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Branded and Branded Generic Inhalers

Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement to six (6) Framework Participants.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

All other Cardiovascular & Respiratory Medicines

Supply of all other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. The Authority has awarded each line within this lot to a single supplier.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

Iloprost Medicines

Supply of Iloprost Solutions for Infusion and Nebuliser solutions, to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi supplier unranked framework agreement on a line by line basis to three (3) suppliers.

Renewal: Option to extend by a further period of up to twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR411459 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 7 Apr 2021 |
| Submission deadline | 21 Dec 2020 |
| Future notice date | Not specified |
| Award date | 4 Mar 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £19,491,306 |
| Lots value | £19,491,306 |
| Awards value | Not specified |
| Contracts value | £105,516,940 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Active, Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 43 |
| Supplier names | ACCORD HEALTHCARE; AGUETTANT; ASPIRE PHARMA; AVENTIS PHARMA LTD TRADING AS SANOFI; BAXTER HEALTHCARE; BOWMED IBISQUS; BROWN AND BURK; CHIESI; CIPLA (EU; COLONIS PHARMA; CONSILIENT HEALTH; CORREVIO; CRESCENT PHARMA; DR REDDY'S LABORATORIES (UK; ENNOGEN HEALTHCARE; FIRSTLINE PHARMA; FOCUS PHARMACEUTICALS; GALEN; GLAXOSMITHKLINE; GLENMARK PHARMACEUTICALS EUROPE; HAMELN PHARMACEUTICALS; INTRAPHARM LABORATORIES; KENT PHARMACEUTICALS; MARTINDALE PHARMA; MERCURY PHARMA GROUP; MORNINGSIDE PHARMACEUTICALS; MYLAN; NAPP PHARMACEUTICALS; NORGINE PHARMACEUTICALS; ORGANON PHARMACEUTICAL; PFIZER; RANBAXY (UK; ROSEMONT PHARMACEUTICALS; SANDOZ; SELECTIVE SUPPLIES; SINTETICA; SYNCHRONY PHARMA; SYRI LIMITED T/A THAME LABORATORIES; TEVA; THORNTON & ROSS; TORRENT PHARMA (UK; WOCKHARDT; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 7 Apr 2021 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR411459
- 17 Nov 2020 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV400012

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV400012
  Cardiovascular & Respiratory Medicines - This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into fifteen (15) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR411459
  Cardiovascular & Respiratory Medicines - This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into fifteen (15) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

## Notice URLs

- http://
- http://www.nhsscotlandprocurement.scot.nhs.uk/
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000635950
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/
- https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000635950. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000635950.json.